Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Hausenloy

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology and Therapeutics|September 14, 2007
Targeting cell deathD J Hausenloy, L Scorrano
Heart (British Cardiac Society)|May 16, 2008
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levelsD J Hausenloy, D M Yellon
Diabetes, Obesity & Metabolism|September 11, 2007
Preconditioning and postconditioning: new strategies for cardioprotectionD J Hausenloy, D M Yellon
Postgraduate Medical Journal|December 24, 2008
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levelsD J Hausenloy, D M Yellon
Anaesthesia|May 12, 2015
Remote ischaemic conditioning: cardiac protection from afarV Sivaraman, J M J Pickard, D J Hausenloy
British Journal of Pharmacology|December 17, 2013
Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular diseaseA R Hall, N Burke, R K Dongworth, et al.
British Journal of Pharmacology|November 14, 2014
Role of the MPTP in conditioning the heart - translatability and mechanismS-B Ong, R K Dongworth, H A Cabrera-Fuentes, et al.
Heart (British Cardiac Society)|June 11, 2009
Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trialV Venugopal, D J Hausenloy, A Ludman, et al.
Cardiovascular Drugs and Therapy|December 31, 2011
Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heartD J Hausenloy, E K Iliodromitis, I Andreadou, et al.
Cell Death & Disease|May 27, 2016
Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarctionA R Hall, N Burke, R K Dongworth, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|September 14, 2007
Targeting cell deathD J Hausenloy, L Scorrano
Heart (British Cardiac Society)|May 16, 2008
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levelsD J Hausenloy, D M Yellon
Diabetes, Obesity & Metabolism|September 11, 2007
Preconditioning and postconditioning: new strategies for cardioprotectionD J Hausenloy, D M Yellon
Postgraduate Medical Journal|December 24, 2008
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levelsD J Hausenloy, D M Yellon
Anaesthesia|May 12, 2015
Remote ischaemic conditioning: cardiac protection from afarV Sivaraman, J M J Pickard, D J Hausenloy
British Journal of Pharmacology|December 17, 2013
Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular diseaseA R Hall, N Burke, R K Dongworth, et al.
British Journal of Pharmacology|November 14, 2014
Role of the MPTP in conditioning the heart - translatability and mechanismS-B Ong, R K Dongworth, H A Cabrera-Fuentes, et al.
Heart (British Cardiac Society)|June 11, 2009
Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trialV Venugopal, D J Hausenloy, A Ludman, et al.
Cardiovascular Drugs and Therapy|December 31, 2011
Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heartD J Hausenloy, E K Iliodromitis, I Andreadou, et al.
Cell Death & Disease|May 27, 2016
Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarctionA R Hall, N Burke, R K Dongworth, et al.
Pageof 2